Torsades de Pointes with QT prolongation related to donepezil use

Journal of Cardiology

Volumn 54, Issue 3, 2009, Pages 507-511

  Takaya, Tomofumi ^a   Okamoto, Masashi ^a   Yodoi, Keiko ^a   Hata, Katsuya ^a   Kijima, Yoichi ^a   Nakajima, Hideto ^a   Nishikawa, Yuji ^a   Kita, Tomoyuki ^a   Ito, Mitsuaki ^a   Seo, Toshihiko ^a   Kawashima, Seinosuke ^a  

^a SAISEIKAI NAKATSU HOSPITAL   (Japan)

Author keywords

Donepezil; QT prolongation; Torsades de Pointes

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BISOPROLOL; BRAIN NATRIURETIC PEPTIDE; CILOSTAZOL; DONEPEZIL; ISOPRENALINE; LIDOCAINE; MAGNESIUM SULFATE; ORCIPRENALINE; POTASSIUM; POTASSIUM CHLORIDE; UREA;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALZHEIMER DISEASE; ANGIOCARDIOGRAPHY; ARTICLE; ARTIFICIAL HEART PACEMAKER; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; COLITIS; CONVULSION; CORONARY ARTERY CIRCUMFLEX BRANCH; CORONARY ARTERY OBSTRUCTION; DIABETES MELLITUS; DIARRHEA; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; ELECTROCARDIOGRAPHY; ELECTROSTIMULATION; FEMALE; HEART ANEURYSM; HEART ATRIUM ENLARGEMENT; HEART ATRIUM FIBRILLATION; HEART EJECTION FRACTION; HEART ELECTROPHYSIOLOGY; HEART INFARCTION; HEART MURMUR; HEART RATE; HEART RHYTHM; HEART VENTRICLE ENDDIASTOLIC PRESSURE; HUMAN; HYPERTENSION; HYPOVOLEMIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LEUKOCYTE COUNT; PALLOR; POTASSIUM BLOOD LEVEL; QT PROLONGATION; RIGHT CORONARY ARTERY; ST SEGMENT ELEVATION; SYNCOPE; THORAX RADIOGRAPHY; TORSADE DES POINTES; TRANSTHORACIC ECHOCARDIOGRAPHY; UREA NITROGEN BLOOD LEVEL; VOMITING;

AGED, 80 AND OVER; ALZHEIMER DISEASE; CHOLINESTERASE INHIBITORS; COLITIS; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; INDANS; ISOPROTERENOL; LIDOCAINE; LONG QT SYNDROME; MAGNESIUM SULFATE; NOOTROPIC AGENTS; PIPERIDINES; POTASSIUM CHLORIDE; SYNCOPE; TORSADES DE POINTES; TREATMENT OUTCOME;

EID: 70450223919     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2009.03.011     Document Type: Article

References (9)

1. Winblad B., Kilander L., Eriksson S., Minthon L., Båtsman S., Wetterholm A.L., Jansson-Blixt C., Haglund A., and Severe Alzheimer's Disease Study Group. Donepezil in patients with severe Alzheimer's disease: double-blind, parallel-group, placebo-controlled study. Lancet 367 (2006) 1057-1065
2. Winblad B., Engedal K., Soininen H., Verhey F., Waldemar G., Wimo A., Wetterholm A.L., Zhang R., Haglund A., Subbiah P., and Donepezil Nordic Study Group. A 1-year, randomized, placebo-controlled study of donepezil in patients with mild to moderate AD. Neurology 57 (2001) 489-495
3. Wolfson C., Wolfson D.B., Asgharian M., M'Lan C.E., Ostbye T., Rockwood K., Hogan D.B., and Clinical Progression of Dementia Study Group. A reevaluation of the duration of survival after the onset of dementia. N Engl J Med 344 (2001) 1111-1116
4. Fisher A.A., and Davis M.W. Prolonged QT interval, syncope, and delirium with galantamine. Ann Pharmacother 42 (2008) 278-283
5. Bordier P., Garrigue S., Barold S.S., Bressolles N., Lanusse S., and Clémenty J. Significance of syncope in patients with Alzheimer's disease treated with cholinesterase inhibitors. Europace 5 (2003) 429-431
6. Bordier P., Garrigue S., Lanusse S., Margaine J., Robert F., Gencel L., and Lafitte A. Cardiovascular effects and risk of syncope related to donepezil in patients with Alzheimer's disease. CNS Drugs 20 (2006) 411-417
7. De ponti F., Poluzzi E., and Montanano N. QT-interval prolongation by non-cardiac drugs: lessons to be learned from recent experience. Eur J Clin Pharmacol 56 (2000) 1-18
8. Roden D.M. Drug-induced prolongation of the QT interval. N Engl J Med 350 (2004) 1013-1022
9. Kato T., Ueno A., and Murata H. The effect of donepezil hydrochloride on QT interval evaluated by objective measurements of electrocardiogram. Jpn J Electrocardiol 27 (2007) 588-595 [in Japanese]